Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

Phase 2

Recruiting

Conditions: Metastatic Cancer
Glioblastoma
Recurrent Glioblastoma
Leptomeningeal Metastasis
Brain Cancer

Interventions: Drug: Trastuzumab deruxtecan

First Posted Date: 2023-09-28

Last Posted Date: 2025-05-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT06058988

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

Not Applicable

Recruiting

Conditions: Malignant Pleural Mesothelioma

Interventions: Diagnostic Test: E-Nose testing
Diagnostic Test: Research blood

First Posted Date: 2023-09-14

Last Posted Date: 2024-07-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 20

Registration Number: NCT06037941

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent Only), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (Consent Only), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

and more 4 locations

Improving Surgeon Performance Measures for Robot-Assisted Surgery

Conditions: Surgery

Interventions: Procedure: Robotic Surgery

First Posted Date: 2023-09-14

Last Posted Date: 2025-05-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1000

Registration Number: NCT06037837

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of Mental Health Care in People With Cancer

Not Applicable

Recruiting

Conditions: Colorectal Cancer
Lung Cancer
Breast Cancer
Prostate Cancer

Interventions: Other: 30-minute telephone or videoconference sessions
Other: Questionnaires
Other: Interviews

First Posted Date: 2023-09-14

Last Posted Date: 2025-04-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 130

Registration Number: NCT06037954

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Using Urine Samples to Identify Lung Cancer

Recruiting

Conditions: Non Small Cell Lung Cancer

Interventions: Diagnostic Test: urine sample

First Posted Date: 2023-09-13

Last Posted Date: 2024-07-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 210

Registration Number: NCT06033248

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States

and more 4 locations

A Study of Blood Pressure Control During Cancer Treatment

Phase 2

Recruiting

Conditions: Breast Cancer
Cardiotoxicity

Interventions: Other: antihypertensive medications
Diagnostic Test: Blood pressure measurement
Diagnostic Test: Echocardiogram
Other: Symptom-limited cardiopulmonary exercise test
Other: Quality of Life Measures
Diagnostic Test: Biomarkers

First Posted Date: 2023-09-05

Last Posted Date: 2025-04-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 130

Registration Number: NCT06023576

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States

and more 4 locations

A Study of CRD3874-SI in People With Solid Tumors

Phase 1

Recruiting

Conditions: Sarcoma
Merkel Cell Carcinoma

Interventions: Drug: CRD3874

First Posted Date: 2023-09-01

Last Posted Date: 2025-05-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 72

Registration Number: NCT06021626

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

Phase 1

Recruiting

Conditions: Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia, in Relapse
Acute Myeloid Leukemia Refractory
Relapsed Acute Myeloid Leukemia
Acute Myeloid Leukemia

Interventions: Biological: CD371-specific/YSNVz/I-18 CAR T cells

First Posted Date: 2023-08-30

Last Posted Date: 2025-05-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 15

Registration Number: NCT06017258

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of Avutometinib and Defactinib in People With Thyroid Cancer

Phase 2

Recruiting

Conditions: Thyroid Cancer

Interventions: Drug: Avutometinib
Drug: Defactinib

First Posted Date: 2023-08-23

Last Posted Date: 2025-02-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT06007924

Locations: 🇺🇸
Lehigh Valley Health Network (Data Collection Only), Allentown, Pennsylvania, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

and more 5 locations

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

Phase 1

Recruiting

Conditions: Non Small Cell Lung Cancer
Metastatic
Recurrent

Interventions: Drug: Lorlatinib
Drug: Ramucirumab

First Posted Date: 2023-08-23

Last Posted Date: 2025-04-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 56

Registration Number: NCT06007937

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center Suffolk - Commack (All Protocol Activities), Commack, New York, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy